Literature DB >> 21741078

Racial disparities in histopathologic characteristics of uterine cancer are present in older, not younger blacks in an equal-access environment.

Kate E Oliver1, Lindsey R Enewold, Kangmin Zhu, Thomas P Conrads, G Scott Rose, G Larry Maxwell, John H Farley.   

Abstract

OBJECTIVE: We sought to determine whether racial disparities in tumor characteristics among uterine cancer patients persisted, and varied by age, in an equal-access healthcare population.
METHODS: The distributions of tumor histology, stage and grade by race were compared for uterine cancers diagnosed from 1990 to 2003 using data from the U.S. Department of Defense's Automated Central Tumor Registry. Comparisons were conducted overall and stratified by age (<50, ≥50) using the Chi-square test.
RESULTS: Of 2582 uterine tumors identified, 2057 (79.7%) were diagnosed among White women and 183 (7.1%) among Black women. Among all women analyzed, Blacks were more likely than Whites to present with non-endometrioid tumors (47.7% vs 23.5%, p<0.01), non-localized tumors (31.8% vs 24.5%, p=0.02), and poorly differentiated tumors (20.5% vs 15.0%, p<0.01). Among women 50 years and older, similar significant racial disparities were observed. However, no significant racial differences were observed among young patients. When comparisons were restricted to endometrioid histology adenocarcinomas, trends in age-specific disparities for older women were observed.
CONCLUSIONS: Our study suggests that racial disparities in uterine cancers persist between Blacks and Whites in an equal-access population. Blacks endure higher stage and grade tumors, and more aggressive histologies. This disparity in clinicopathologic factors is confined to women older than 50 years. Multiple factors such as racial variation in age-related health knowledge/behavior and estrogen metabolism may be related to the racial disparity. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21741078     DOI: 10.1016/j.ygyno.2011.06.027

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  17 in total

1.  Racial disparities in young women with endometrial cancer.

Authors:  Barenya Mukerji; Caitlin Baptiste; Ling Chen; Ana I Tergas; June Y Hou; Cande V Ananth; Alfred I Neugut; Dawn L Hershman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2018-01-05       Impact factor: 5.482

Review 2.  Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.

Authors:  Yvonne Collins; Kevin Holcomb; Eloise Chapman-Davis; Dineo Khabele; John H Farley
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

3.  Impact of age at diagnosis on racial disparities in endometrial cancer patients.

Authors:  Christopher M Tarney; Chunqiao Tian; Guisong Wang; Elizabeth A Dubil; Nicholas W Bateman; John K Chan; Mohamed A Elshaikh; Michele L Cote; Joellen M Schildkraut; Craig D Shriver; Thomas P Conrads; Chad A Hamilton; G Larry Maxwell; Kathleen M Darcy
Journal:  Gynecol Oncol       Date:  2017-08-08       Impact factor: 5.482

4.  Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer.

Authors:  N M de Lange; N P M Ezendam; J S Kwon; I Vandenput; D Mirchandani; F Amant; L J M van der Putten; J M A Pijnenborg
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

5.  The Military Health Care System May Have the Potential to Prevent Health Care Disparities.

Authors:  Bosny J Pierre-Louis; Angelo D Moore; Jill B Hamilton
Journal:  J Racial Ethn Health Disparities       Date:  2014-12-06

Review 6.  Controversies in the Management of Early-stage Serous Endometrial Cancer.

Authors:  Alyssa Larish; Andrea Mariani; Carrie Langstraat
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 7.  Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States.

Authors:  B Long; F W Liu; R E Bristow
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

Review 8.  Malignant tumors of the uterine corpus: molecular background of their origin.

Authors:  D Brany; D Dvorska; M Nachajova; P Slavik; T Burjanivova
Journal:  Tumour Biol       Date:  2015-08-26

9.  Racial disparities in survival among women with endometrial cancer in an equal access system.

Authors:  Amie B Park; Kathleen M Darcy; Chunqiao Tian; Yovanni Casablanca; Jill K Schinkel; Lindsey Enewold; Katherine A McGlynn; Craig D Shriver; Kangmin Zhu
Journal:  Gynecol Oncol       Date:  2021-07-27       Impact factor: 5.482

10.  Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation.

Authors:  Ebony R Hoskins; Brian L Hood; Mai Sun; Thomas C Krivak; Robert P Edwards; Thomas P Conrads
Journal:  PLoS One       Date:  2011-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.